APLLTDstockAlembic Pharmaceuticals Ltd
₹745.1
▼-0.25%
Open
₹747
High
₹753
Low
₹742.4
Volume
48.8K
Price chart
Daily close · downsampled 5-year history
2021-06-21 · ₹1,000.72026-06-18 · ₹745
Instrument details
- MB Code
- MBEQU413
- Type
- stock
- ISIN
- INE901L01018
- BSE
- 533573
- Industry
- Pharmaceuticals & Biotechnology
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 1847.72 Cr
- Net profit
- 201.53 Cr
- EPS
- 10.31
- YoY revenue
- +4.41%
Price returns
Historical performance
- 1 day
- -0.08%
- 1 month
- -0.91%
- 3 months
- +10.04%
- 1 year
- -22.31%
- 3 years
- +21.75%
- 5 years
- -23.63%
Technicals
Indicator consensus
Bullish
23
Neutral
7
Bearish
16
RSI 61.60(Neutral)
Company documents
Annual reports, concalls, presentations
Concall transcripts
58Investor presentations
38Corporate announcements
446Corporate timeline
Price chart events · 1 year
Dividend
2025-07-29
{"amount":11}
Earnings
2026-05-15
{"actualRevenue":18477200000,"estimateRevenue":19222000000,"revenueSurprise":-744800000,"revenueSurprisePercent":-3.874726875455207,"actualEPS":11.57,"estimateEPS":8.484,"surprise":3.086,"surprisePercent":36.37435172088638}
Earnings
2025-08-05
{"actualRevenue":17107200000,"estimateRevenue":17572000000,"revenueSurprise":-464800000,"revenueSurprisePercent":-2.645117231959936,"actualEPS":7.85,"estimateEPS":7.675999999999999,"surprise":0.1740000000000004,"surprisePercent":2.266805627931219}
Earnings
2026-02-05
{"actualRevenue":18763100000,"estimateRevenue":18629000000,"revenueSurprise":134100000,"revenueSurprisePercent":0.719845402329701,"actualEPS":8.91,"estimateEPS":8.383000000000001,"surprise":0.5269999999999992,"surprisePercent":6.28653226768459}
Earnings
2025-11-04
{"actualRevenue":19101500000,"estimateRevenue":18196000000,"revenueSurprise":905500000,"revenueSurprisePercent":4.976368432622555,"actualEPS":9.4,"estimateEPS":9.1573367,"surprise":0.2426633000000002,"surprisePercent":2.64993314049488}
News
2026-05-15
{"description":"Alembic Pharmaceuticals posted a 29% YoY rise in Q4 net profit to ₹202 crore on May 15, 2026, with revenue up 4.4%; it declared a ₹12 per share dividend and launched Pivya in the US.","url":"https://www.cnbctv18.com/market/stocks/alembic-pharma-share-price-q4-profit-up-29-as-us-formulations-business-grows-11-declares-rs-12-dividend-19906845.htm","sentiment":"Positive","domain":"CNBCTV18"}
News
2025-06-26
{"description":"Alembic Pharmaceuticals' share price on June 20, 2025, shows a buy rating from analysts, with no sell ratings. The company reported a net profit of 156.87. Stay updated with live NSE/BSE rates and expert forecasts.","url":"https://www.livemint.com/market/market-stats/stocks-alembic-pharmaceuticals-share-price-nse-bse-s0003266","sentiment":"Neutral","domain":"Mint"}